Literature DB >> 16721708

[Guideline conformance for outpatient management of COPD in Germany].

T Glaab1, N Banik, C Singer, M Wencker.   

Abstract

BACKGROUND AND
OBJECTIVE: Primary care physicians (PCPs) are the ones mainly responsible for the initial diagnosis and outpatient care of patients with COPD. The aim of the present survey was to investigate their initial management of COPD in Germany based on current guidelines and to identify any deviations.
METHODS: A prospective cross-sectional survey was conducted as a multiple-choice questionnaire sent out to 1836 PCPs in seven Federal States of Germany (one large town and surrounding country in each). The product-neutral questions focused on the key aspects of current national and international (GLOBAL) COPD guidelines.
RESULTS: 486 physicians participated in the study (response rate 26.5%). 66.5% of the physicians used the German COPD guidelines, 20.8% used GOLD guidelines, and only 11.7% observed no guidelines. The physicians were aware of the epidemiological and public health significance of COPD. 76.5% saw spirometry as the diagnostic standard: it was available in 90.1% of the practices. However, only 60-65% were able to cite the correct spirometric criteria for classifying severity of the disease. Educational measures to help patients quit smoking and the teaching and monitoring of patients' inhalation technique were inadequately implemented. The two most important therapeutic goals cited were to improve quality of life (69.1%) and prevent exacerbations (53.1%). Except for the criteria for the use of steroids and the implementation of pulmonary rehabilitation measures, treatment of COPD based on severity class was largely in compliance with the guidelines. However, a significant percentage of the physicians incorrectly assessed the evidence-based clinical benefits of various therapeutic measures.
CONCLUSION: The study shows that, despite the high regard in which COPD guidelines are held, deficiencies exist with regard to the diagnosis and treatment of COPD and the practical implementation of educational measures.

Entities:  

Mesh:

Year:  2006        PMID: 16721708     DOI: 10.1055/s-2006-941752

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  7 in total

1.  Pulmonary rehabilitation: overwhelming evidence but lost in translation?

Authors:  Kylie Johnston; Karen Grimmer-Somers
Journal:  Physiother Can       Date:  2010-10-18       Impact factor: 1.037

2.  Medical Treatment of COPD.

Authors:  Jana Graf; Rudolf A Jörres; Tanja Lucke; Dennis Nowak; Claus F Vogelmeier; Joachim H Ficker
Journal:  Dtsch Arztebl Int       Date:  2018-09-14       Impact factor: 5.594

3.  Why are some evidence-based care recommendations in chronic obstructive pulmonary disease better implemented than others? Perspectives of medical practitioners.

Authors:  Kylie N Johnston; Mary Young; Karen A Grimmer-Somers; Ral Antic; Peter A Frith
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-12-06

4.  Patients with COPD who underwent pulmonary rehabilitation in Turkey: prevalence, distribution, and mortality

Authors:  Tarkan Özdemir; Ipek Candemir; Pinar Ergün; Mustafa Hamidullah Türkkani; Orhan Koç
Journal:  Turk J Med Sci       Date:  2020-02-13       Impact factor: 0.973

5.  Integration of complementary and alternative medicine into family practices in Germany: results of a national survey.

Authors:  Stefanie Joos; Berthold Musselmann; Joachim Szecsenyi
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-19       Impact factor: 2.629

6.  Antibiotics used in the ambulatory management of acute COPD exacerbations.

Authors:  Marie-France Beauchesne; Marcel Julien; Louis-André Julien; Dominique Piquette; Amélie Forget; Manon Labrecque; Lucie Blais
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

7.  Who is where at risk for Chronic Obstructive Pulmonary Disease? A spatial epidemiological analysis of health insurance claims for COPD in Northeastern Germany.

Authors:  Boris Kauhl; Werner Maier; Jürgen Schweikart; Andrea Keste; Marita Moskwyn
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.